2024/10/18 21:31:22 | |
---|---|
Price | |
218.00 EUR | |
Difference | 1.87% (4.00) |
ISIN | US8793691069 |
Symbol | TFX |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 10,440 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - (0) |
Ask (Ask size) | - (0) |
Open | 212.00 EUR |
High | 218.00 EUR |
Low | 212.00 EUR |
Close (prev. day) | 214.00 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 3 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/18 21:31:22 | |
---|---|
Price | |
218.00 EUR | |
Difference | 1.87% (4.00) |
ISIN | US8793691069 |
Symbol | TFX |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 10,440 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - (0) |
Ask (Ask size) | - (0) |
Open | 212.00 EUR |
High | 218.00 EUR |
Low | 212.00 EUR |
Close (prev. day) | 214.00 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 3 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +12.95% | +21.11% | -29.22% |
Perf (abs.) | +25.00 | +38.00 | -90.00 |
Beta | 0.29 | 0.74 | 0.87 |
Volatility | 26.74 | 29.36 | 33.38 |
Ø price 5 days | Ø volume 5 days (pcs.) | 215.20 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 216.53 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 206.36 EUR (0) |
Ø price 250 days | Ø volume 250 days (pcs.) | 205.66 EUR (0) |
YTD High | date | 236.00 EUR (2024/02/16) |
YTD Low | date | 182.00 EUR (2024/06/26) |
52 Weeks High | date | 236.00 EUR (2024/02/16) |
52 Weeks Low | date | 166.00 EUR (2023/10/31) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/10/18 | 22:26 | 222.00 EUR | 0.00 | 1 |
Stuttgart | 2024/10/18 | 21:31 | 218.00 EUR | 0.00 | 3 |
NYSE | 2024/10/18 | 22:00 | 239.94 USD | 103.09 | 8,902 |
Munich | 2024/10/18 | 08:01 | 216.00 EUR | 0.00 | 1 |
Hanover | 2024/10/18 | 17:25 | 218.00 EUR | 0.00 | 4 |
Frankfurt | 2024/10/18 | 08:12 | 212.00 EUR | 0.00 | 2 |
Duesseldorf | 2024/10/18 | 08:11 | 210.00 EUR | 0.00 | 3 |
TELEFLEX INC. |
- - |
550 East Swedesford Road, Suite 400 - 19087 Wayne |
Telefon: +1-610-225-6800 |
Fax: + |
E-mail: - |
Teleflex, Inc. provides medical technology products which enable healthcare providers to improve patient outcomes and enhance patient and provider safety. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA. |
Jaewon Ryu | Member of Board of Directors |
Stephen Klasko | Member of Board of Directors |
Andrew Krakauer | Member of Board of Directors |
Candace Duncan | Member of Board of Directors |
Gretchen Haggerty | Member of Board of Directors |
John Heinmiller | Member of Board of Directors |
Neena Patil | Member of Board of Directors |
Stuart Randle | Member of Board of Directors |
Liam J. Kelly | Chairman of Managing Board |
Cameron Hicks | Member of Executive Committee |
Howard Cyr | Member of Executive Committee |
Michelle Fox | Member of Executive Committee |
Thomas Powell | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer